3,572 Shares in Grail, Inc. (NASDAQ:GRAL) Acquired by Wilmington Savings Fund Society FSB

Wilmington Savings Fund Society FSB acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 3,572 shares of the company’s stock, valued at approximately $64,000.

Several other hedge funds have also added to or reduced their stakes in the company. FNY Investment Advisers LLC acquired a new stake in shares of Grail during the 4th quarter worth approximately $26,000. China Universal Asset Management Co. Ltd. bought a new position in Grail in the 4th quarter valued at approximately $127,000. Perigon Wealth Management LLC acquired a new position in shares of Grail during the fourth quarter worth $260,000. B & T Capital Management DBA Alpha Capital Management acquired a new position in Grail during the 4th quarter worth about $387,000. Finally, A. D. Beadell Investment Counsel Inc. bought a new stake in Grail in the fourth quarter valued at approximately $430,000.

Grail Price Performance

GRAL stock opened at $52.58 on Friday. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $52.85. The stock’s fifty day simple moving average is $22.67 and its two-hundred day simple moving average is $17.58.

Grail (NASDAQ:GRAL) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($3.94) EPS for the quarter. The company had revenue of $28.65 million for the quarter. On average, equities research analysts forecast that Grail, Inc. will post -65.16 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Aaron Freidin sold 30,452 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the transaction, the chief financial officer now directly owns 268,277 shares of the company’s stock, valued at approximately $3,761,243.54. This trade represents a 10.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Analyst Ratings Changes

Several research analysts have recently weighed in on GRAL shares. Wolfe Research assumed coverage on Grail in a research report on Friday, November 15th. They issued a “peer perform” rating for the company. Guggenheim initiated coverage on shares of Grail in a research note on Thursday, October 17th. They issued a “neutral” rating on the stock. Finally, Morgan Stanley started coverage on Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price on the stock.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.